Decline in American marten occupancy rates at Sagehen Experimental Forest,California

We compared the distribution and frequency of American marten (Martes americana) detections during historic surveys and a recent survey on the Sagehen Experimental Forest (SEF) in the Sierra Nevada Mountains, California. This area has been the location of 9 previous marten surveys during 1980–1993, each involving a systematic detection/non-detection survey on the same grid. These data are a time series of information on the occupancy of martens that can be related to habitat change in the study area. Our objectives were to 1) resurvey martens in SEF using methodology similar to previous studies to assess current marten occupancy; 2) evaluate changes in marten occupancy during the period 1980–2008; and 3) examine associations between marten occurence and changes in habitat and landscape metrics. Current marten occupancy was estimated using surveys conducted in summer 2007, winter 2007–2008, and summer 2008. From 1978 to 2007 there was a decrease in predicted habitat patch size, core area, and total amount of marten habitat in the study area, as well as an increase in distance between patches. Marten detections in 2007–2008 were approximately 60% lower than in surveys in the 1980s. We detected no martens in the summers of 2007 and 2008, and 10 detections in winter 2007–2008 were limited to higher elevations in the southwestern portion of SEF. No martens were detected in the lower elevations where most of the recent forest management activity occurred. We suggest that the marten population at SEF has been negatively affected by the loss and fragmentation of habitat. We recommend that future management of forests in the Sagehen basin focus on restoring and connecting residual marten habitat to improve habitat quality for martens. © 2011 The Wildlife Society.     

Specific Activity of Brain Palmitoyl-CoA Pool Provides Rates of Incorporation of Palmitate in Brain Phospholipids in Awake Rats

Abstract: In vivo rates of palmitate incorporation into brain phospholipids were measured in awake rats following programmed intravenous infusion of unesterified [9,10-³H]palmitate to maintain constant plasma specific activity. Animals were killed after 2–10 min of infusion by microwave irradiation and analyzed for tracer distribution in brain phospholipid and phospholipid precursor, i.e., brain unesterified palmitate and palmitoyl-CoA, pools. [9,10-³H]Palmitate incorporation into brain phospholipids was linear with time and rapid, with >50% of brain tracer in choline-containing glycerophospholipids at 2 min of infusion. However, tracer specific activity in brain phospholipid precursor pools was low and averaged only 1.6–1.8% of plasma unesterified palmitate specific activity. Correction for brain palmitoyl-CoA specific activity increased the calculated rate of palmitate incorporation into brain phospholipids (0.52 nmol/s/g) by ∼60-fold. The results suggest that palmitate incorporation and turnover in brain phospholipids are far more rapid than generally assumed and that this rapid turnover dilutes tracer specific activity in brain palmitoyl-CoA pool owing to release and recycling of unlabeled fatty acid from phospholipid breakdown.     

Mouse Chromosome 7

Chair of Committee for Mouse Chromosome 7     

Rapid production of a chimeric antibody-antigen fusion protein based on 2A-peptide cleavage and green fluorescent protein expression in CHO cells

To enable large-scale antibody production, the creation of a stable, high producer cell line is essential. This process often takes longer than 6 months using standard limited dilution techniques and is very labor intensive. The use of a tri-cistronic vector expressing green fluorescent protein (GFP) and both antibody chains, separated by a GT2A peptide sequence, allows expression of all proteins under a single promotor in equimolar ratios. By combining the advantages of 2A peptide cleavage and single cell sorting, a chimeric antibody-antigen fusion protein that contained the variable domains of mouse IgG with a porcine IgA constant domain fused to the FedF antigen could be produced in CHO-K1 cells. After transfection, a strong correlation was found between antibody production and GFP expression (r = 0.69) using image analysis of formed monolayer patches. This enables the rapid selection of GFP-positive clones using automated image analysis for the selection of high producer clones. This vector design allowed the rapid selection of high producer clones within a time-frame of 4 weeks after transfection. The highest producing clone had a specific antibody productivity of 2.32 pg/cell/day. Concentrations of 34 mg/L were obtained using shake-flask batch culture. The produced recombinant antibody showed stable expression, binding and minimal degradation. In the future, this antibody will be assessed for its effectiveness as an oral vaccine antigen.